US 8242074
Modulation of the amount or function of pathogenic CD14+CD16+ monocytes
granted A61KA61K2039/505A61P
Quick answer
US patent 8242074 (Modulation of the amount or function of pathogenic CD14+CD16+ monocytes) held by XBIOTECH INC. expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- XBIOTECH INC.
- Grant date
- Tue Aug 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K2039/505, A61P, A61P1/04, A61P19/02